Brief: HeartBeam Partners With Evolve Manufacturing To Build HeartBeam AIMIGoTM 12-Lead 3D Vector Electrocardiogram Device
Brief: New Heartbeam Patent For 12-Lead Electrocardiogram Smartwatch-Based Monitor Intended For Detection Of Heart Attacks And Complex Cardiac Arrhythmias
Heartbeam Inc reports results for the quarter ended in September - Earnings Summary
Brief: HeartBeam Reports Third Quarter 2022 Financial Results
Heartbeam Inc expected to post a loss of 32 cents a share - Earnings Preview
Brief: Heartbeam Names Peter J. Fitzgerald, MD, PHD, As Chief Medical Officer
U.S. STOCKS ON THE MOVE-Heartbeam, Aura Biosciences, U.S. banks
Heartbeam Inc gains on U.S. patent for heart device
Brief: Heartbeam Inc - Heartbeam Granted Patent For Signal Transformation From Vector Electrocardiogram (VECG) To 12-Lead Electrocardiogram (ECG)
U.S. STOCKS ON THE MOVE-HeartBeam, Duckhorn Portfolio, Danaher
HeartBeam surges on U.S. patent for heart device
U.S. STOCKS ON THE MOVE-Adobe, Netflix, FTC Solar
Brief: HeartBeam Granted Patent For ECG Patch Monitor For Detection Of Heart Attacks
Brief: Heartbeam announces FDA submission of Heartbeam Aimi™ product
Brief: Heartbeam Reports Second Quarter 2022 Financial Results
Brief: Heartbeam Inc Expects To File 510K No Later Than August 15, 2022
Brief: Heartbeam Reports First Quarter 2022 Financial Results
Brief: Heartbeam Reports Fourth Quarter And Full Year 2021 Financial Results
Brief: Heartbeam Inc - On January 31, Entered Into A Partnership Agreement With Livmor